Annual Operating Expenses
$24.42 B
+$486.00 M+2.03%
31 December 2023
Summary:
Novartis AG annual total operating expenses is currently $24.42 billion, with the most recent change of +$486.00 million (+2.03%) on 31 December 2023. During the last 3 years, it has fallen by -$206.00 million (-0.84%). NVS annual operating expenses is now -17.54% below its all-time high of $29.61 billion, reached on 31 December 2011.NVS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$6.31 B
+$626.00 M+11.01%
30 September 2024
Summary:
Novartis AG quarterly total operating expenses is currently $6.31 billion, with the most recent change of +$626.00 million (+11.01%) on 30 September 2024. Over the past year, it has dropped by -$902.00 million (-12.51%). NVS quarterly operating expenses is now -28.11% below its all-time high of $8.78 billion, reached on 31 December 2011.NVS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVS Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.0% | -12.5% |
| 3 y3 years | -0.8% | +1.9% |
| 5 y5 years | +5.3% | -0.6% |
NVS Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -0.8% | +10.1% | -12.5% | +64.1% |
| 5 y | 5 years | -3.0% | +10.1% | -12.5% | +64.1% |
| alltime | all time | -17.5% | +151.9% | -28.1% | +184.3% |
Novartis AG Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.31 B(+11.0%) |
| June 2024 | - | $5.68 B(+0.6%) |
| Mar 2024 | - | $5.65 B(-8.4%) |
| Dec 2023 | $24.42 B(+2.0%) | $6.17 B(-14.4%) |
| Sept 2023 | - | $7.21 B(+28.9%) |
| June 2023 | - | $5.60 B(+2.9%) |
| Mar 2023 | - | $5.44 B(-11.9%) |
| Dec 2022 | $23.93 B(+7.9%) | $6.17 B(+1.4%) |
| Sept 2022 | - | $6.08 B(-14.4%) |
| June 2022 | - | $7.11 B(+16.4%) |
| Mar 2022 | - | $6.11 B(+58.8%) |
| Dec 2021 | $22.18 B(-9.9%) | $3.85 B(-37.9%) |
| Sept 2021 | - | $6.20 B(+5.0%) |
| June 2021 | - | $5.90 B(-5.4%) |
| Mar 2021 | - | $6.24 B(+1.2%) |
| Dec 2020 | $24.63 B(-2.1%) | $6.17 B(-3.2%) |
| Sept 2020 | - | $6.37 B(+9.1%) |
| June 2020 | - | $5.84 B(-6.4%) |
| Mar 2020 | - | $6.24 B(-9.5%) |
| Dec 2019 | $25.17 B(+8.5%) | $6.90 B(+8.7%) |
| Sept 2019 | - | $6.35 B(+6.6%) |
| June 2019 | - | $5.96 B(-0.1%) |
| Mar 2019 | - | $5.96 B(-8.2%) |
| Dec 2018 | $23.19 B(+10.0%) | $6.50 B(+14.3%) |
| Sept 2018 | - | $5.68 B(+0.4%) |
| June 2018 | - | $5.66 B(+6.0%) |
| Mar 2018 | - | $5.34 B(+59.8%) |
| Dec 2017 | $21.07 B(-10.9%) | $3.34 B(-44.4%) |
| Sept 2017 | - | $6.01 B(+0.9%) |
| June 2017 | - | $5.96 B(+3.4%) |
| Mar 2017 | - | $5.76 B(-13.6%) |
| Dec 2016 | $23.65 B(-1.5%) | $6.66 B(+16.8%) |
| Sept 2016 | - | $5.70 B(-7.0%) |
| June 2016 | - | $6.13 B(+19.2%) |
| Mar 2016 | - | $5.15 B(-21.8%) |
| Dec 2015 | $24.01 B(-4.7%) | $6.58 B(+12.2%) |
| Sept 2015 | - | $5.86 B(-4.3%) |
| June 2015 | - | $6.13 B(+12.7%) |
| Mar 2015 | - | $5.44 B(-17.5%) |
| Dec 2014 | $25.20 B(+0.2%) | $6.59 B(+7.3%) |
| Sept 2014 | - | $6.14 B(-3.9%) |
| June 2014 | - | $6.39 B(+4.9%) |
| Mar 2014 | - | $6.09 B(-11.4%) |
| Dec 2013 | $25.15 B(+2.3%) | $6.87 B(+10.4%) |
| Sept 2013 | - | $6.22 B(+1.0%) |
| June 2013 | - | $6.16 B(-8.1%) |
| Mar 2013 | - | $6.70 B(+46.8%) |
| Dec 2012 | $24.60 B | $4.57 B(-29.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $6.52 B(-4.5%) |
| June 2012 | - | $6.82 B(+1.9%) |
| Mar 2012 | - | $6.69 B(-23.8%) |
| Dec 2011 | $29.61 B(+15.9%) | $8.78 B(+20.3%) |
| Sept 2011 | - | $7.29 B(+1.6%) |
| June 2011 | - | $7.18 B(+13.0%) |
| Mar 2011 | - | $6.36 B(-14.9%) |
| Dec 2010 | $25.55 B(+11.4%) | $7.47 B(+13.7%) |
| Sept 2010 | - | $6.57 B(+14.2%) |
| June 2010 | - | $5.75 B(+0.1%) |
| Mar 2010 | - | $5.75 B(-16.0%) |
| Dec 2009 | $22.94 B(+3.4%) | $6.84 B(+23.2%) |
| Sept 2009 | - | $5.55 B(-0.0%) |
| June 2009 | - | $5.55 B(+11.2%) |
| Mar 2009 | - | $4.99 B(-14.4%) |
| Dec 2008 | $22.18 B(+5.0%) | $5.83 B(+2.8%) |
| Sept 2008 | - | $5.67 B(+1.4%) |
| June 2008 | - | $5.59 B(+10.1%) |
| Mar 2008 | - | $5.08 B(-25.9%) |
| Dec 2007 | $21.13 B(+17.1%) | $6.85 B(+44.5%) |
| Sept 2007 | - | $4.74 B(-2.4%) |
| June 2007 | - | $4.86 B(+6.7%) |
| Mar 2007 | - | $4.55 B(-13.3%) |
| Dec 2006 | $18.05 B(+14.2%) | $5.25 B(+16.3%) |
| Sept 2006 | - | $4.52 B(+7.1%) |
| June 2006 | - | $4.22 B(+7.9%) |
| Mar 2006 | - | $3.91 B(+2.8%) |
| Dec 2005 | $15.81 B(+9.3%) | $3.80 B(-8.4%) |
| Sept 2005 | - | $4.15 B(+2.6%) |
| June 2005 | - | $4.05 B(+6.3%) |
| Mar 2005 | - | $3.81 B(+7.6%) |
| Dec 2004 | $14.46 B(+12.6%) | $3.54 B(-5.0%) |
| Sept 2004 | - | $3.73 B(+4.0%) |
| June 2004 | - | $3.58 B(-0.7%) |
| Mar 2004 | - | $3.61 B(+10.3%) |
| Dec 2003 | $12.84 B(+19.0%) | $3.27 B(+1.0%) |
| Sept 2003 | - | $3.24 B(-2.3%) |
| June 2003 | - | $3.32 B(+10.3%) |
| Mar 2003 | - | $3.01 B(+4.7%) |
| Dec 2002 | $10.79 B(+11.3%) | $2.87 B(+10.2%) |
| Sept 2002 | - | $2.61 B(-8.8%) |
| June 2002 | - | $2.86 B(+25.4%) |
| Dec 2001 | $9.69 B(-11.5%) | - |
| June 2001 | - | $2.28 B(+2.7%) |
| Dec 2000 | $10.96 B(+3.8%) | - |
| June 2000 | - | $2.22 B |
| Dec 1999 | $10.55 B(-1.4%) | - |
| Dec 1998 | $10.70 B | - |
FAQ
- What is Novartis AG annual total operating expenses?
- What is the all time high annual operating expenses for Novartis AG?
- What is Novartis AG annual operating expenses year-on-year change?
- What is Novartis AG quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Novartis AG?
- What is Novartis AG quarterly operating expenses year-on-year change?
What is Novartis AG annual total operating expenses?
The current annual operating expenses of NVS is $24.42 B
What is the all time high annual operating expenses for Novartis AG?
Novartis AG all-time high annual total operating expenses is $29.61 B
What is Novartis AG annual operating expenses year-on-year change?
Over the past year, NVS annual total operating expenses has changed by +$486.00 M (+2.03%)
What is Novartis AG quarterly total operating expenses?
The current quarterly operating expenses of NVS is $6.31 B
What is the all time high quarterly operating expenses for Novartis AG?
Novartis AG all-time high quarterly total operating expenses is $8.78 B
What is Novartis AG quarterly operating expenses year-on-year change?
Over the past year, NVS quarterly total operating expenses has changed by -$902.00 M (-12.51%)